The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Adrenocortical carcinoma in the United States: Treatment utilization and prognostic factors
Abstract
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare tumor with a relatively poor prognosis. The authors' objectives were to examine treatment utilization and factors associated with long-term survival after resection of ACC in a large, national, patient population. METHODS: Patients diagnosed with ACC from 1985 to 2005 were identified from the National Cancer Data Base (NCDB). Patient, tumor, treatment, and hospital factors associated with survival after resection were examined. RESULTS: For the current study, 3982 patients with ACC were identified. Median age at diagnosis was 55 years. Median tumor size was 13 cm. Of the patients with nodes examined, 26.5% had nodal metastases. Distant metastases were found on presentation in 21.6% of patients. A total of 57.4% of patients underwent surgical resection alone, whereas 16.0% underwent resection with adjuvant chemotherapy or radiation. A total of 19.4% had margin-positive resections. Treatment utilization remained unchanged from 1985 to 2005 (P = .28). Median follow-up was 24 months. Overall 5-year survival for all patients who underwent resection was 38.6% (median survival, 31.9 months). Multivariable analysis demonstrated a higher risk of death with increasing age, poorly differentiated tumors, involved margins, and nodal or distant metastases. Overall survival remained unchanged from 1985 to 2000 (P = .08). CONCLUSIONS: ACC carries a poor prognosis for patients commonly presenting with large, locally invasive tumors, involved margins, and metastatic disease. Survival is not affected by size but is diminished with increasing age, poorly differentiated tumors, involved margins, and the presence of regional and distant disease. Identification of novel therapies may help to increase survival, which has remained unchanged over the last 20 years.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Analysis of the SEER database gives a slightly older mean age of 55 years (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“However, in the United States, 45% of adrenalectomies for ACC are performed in community hospitals, 30% in academic centers, and only 15% in National Cancer Institute-designated Cancer Centers, suboptimal treatment of a rare and aggressive disease requiring specialized knowledge of surgical technique (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“an analysis of almost 4000 patients from the National Cancer Data Base, which found that 9% of ACC patients treated with surgery had microscopically positive margins (R1), whereas a further 10% had macroscopically positive margins (R2) (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“The outcomes after surgical resection alone have remained suboptimal (11, 244, 267, 269–273).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“patients with positive margins had a dismal prognosis compared with those with uninvolved margins; 5-year survival was 10% after R2 resection, 21% after R1, and 49% after R0 (11).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“ACC has a well-documented propensity for lymphatic dissemination (11, 91, 351), with involved nodal disease in approximately 15% to 27% of patients at the time of surgery (11, 91).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
In the citing paper
“In the United States, it is used in approximately 10% of cases, according to analyses of both the National Cancer Data Base and the SEER program (4, 11, 90).”
From Adrenocortical carcinoma (2014) · cites this paper as [11]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10 · Cited by 2,097
Spiess, P. E., Lee, A. K., Leibovici, D., Wang, X., Do, K.-A., & Pisters, L. L. (2006) · Cancer · doi:10.1002/cncr.21979 · Cited by 1,930
The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
Bilimoria, K. Y., Stewart, A. K., Winchester, D. P., & Ko, C. Y. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9747-3 · Cited by 1,853
Self-citationComparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
Weiss, L. M. (1984) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198403000-00001 · Cited by 920
Adrenocortical Carcinoma: Clinical Update
Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma
Terzolo, M., Angeli, A., Faßnacht, M., Daffara, F., Tauchmanovà, L., Conton, P. A., Rossetto, R., Buci, L., Sperone, P., Grossrubatscher, E. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063360 · Cited by 759
Icard, P., Goudet, P., Charpenay, C., Andreassian, B., Carnaille, B., Chapuis, Y., Cougard, P., Henry, J., & Proye, C. (2001) · World Journal of Surgery · doi:10.1007/s00268-001-0047-y · Cited by 543
Flagged first, then by citations
Research works printed but not linked: 3
- 1990, International Classification of Disease for Oncology
- 2000, International Classification of Disease for Oncology
- 2004, Facility Oncology Registry Data Standards
Cited by
Sorted by citations
Items 301–400 of 494
ALTIERI, B., Lalli, E., & Faggiano, A. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03601-0 · Cited by 5
Arnon, J., Grozinsky‐Glasberg, S., Oleinikov, K., Gross, D. J., Salmon, A. Y., Meirovitz, A., & Maimon, O. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac112 · Cited by 5
Treatment of adrenocortical carcinoma: oncological and endocrine outcomes
Brönimann, S., Garstka, N., & Mesut Remzi, A. (2022) · Current Opinion in Urology · doi:10.1097/mou.0000000000001045 · Cited by 5
Khosla, D., Kapoor, R., Singla, A. K., Periasamy, K., Goyal, S., Madan, R., Kumar, N., Behera, A., Singh, S. K., Bhadada, S. K., et al. (2023) · Rare Tumors · doi:10.1177/20363613231160699 · Cited by 5
Logan, C. D., Nunnally, S. E. A., Valukas, C. S., Warwar, S., Swinarska, J. T., Lee, F. T., Bentrem, D. J., Odell, D. D., Elaraj, D. M., & Sturgeon, C. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27387 · Cited by 5
Self-citationSzkodziak, P. R. (2024) · American Journal of Cancer Research · doi:10.62347/qkwf9884 · Cited by 5
Overview of Genetic Syndromes Associated with Adrenocortical Cancer
Else, T. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_10 · Cited by 5
Brutsaert, E. F., Sasano, H., Unger, P. D., Beasley, M. B., Golden, B. K., Inabnet, W. B., & Levine, A. C. (2012) · Endocrine Practice · doi:10.4158/ep12018.cr · Cited by 5
Epigenetic dysregulation in adrenocortical carcinoma, a systematic review of the literature
Jonker, P., Meyer, V., & Kruijff, S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.009 · Cited by 5
Giant Adrenocortical Carcinoma: A Case Report and Review of the Relevant Literature
Mantzoros, I., Bitsianis, S., Loutzidou, L., Ntampakis, G., Chatzakis, C., Christidis, P., Gkiouliava, A., Koraki, E., & Aggelopoulos, S. (2021) · American Journal of Case Reports · doi:10.12659/ajcr.928875 · Cited by 5
Japanese single-institution analysis of mitotane for patients with adrenocortical carcinoma
Ohmoto, A., Shigematsu, Y., Fukuda, N., Wang, X., Urasaki, T., Hayashi, N., Sato, Y., Nakano, K., Yunokawa, M., Ono, M., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0277 · Cited by 5
Clinical and Histopathological Variables and Prognostic Factors of Adrenocortical Carcinoma
Sohail, S., Azmat, U., Khawaja, S. N., Mir, K., Azam, M., Syed, M., Mushtaq, S., Hassan, U., Siddiqui, A., Raza, S. A., et al. (2021) · Cureus · doi:10.7759/cureus.15721 · Cited by 5
Factors Associated with Non–Operative Management of Resectable Adrenocortical Carcinoma
Tseng, J., DiPeri, T. P., Chen, Y., Ben-Shlomo, A., Shouhed, D., Phillips, E. H., Burch, M. A., & Jain, M. (2021) · Journal of Surgical Research · doi:10.1016/j.jss.2021.06.013 · Cited by 5
Naffouje, S. A., Sabesan, A. C., Johnson, J. E. H., Kirtane, K., Gonzalez, R. J., & Mullinax, J. E. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26639 · Cited by 5
Surgical resection for adrenocortical carcinoma: Current trends affecting survival
Shah, M., NeMoyer, R. E., Kashyap, R., Lin, Y., Sarmiento, J. M., Kooby, D. A., Maithel, S. K., Gillespie, T. W., Laird, A. M., & Shah, M. M. (2022) · Journal of Surgical Oncology · doi:10.1002/jso.26845 · Cited by 5
Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review
Chang-fen, X., Xu, P., Zhang, J., he, S. T., Hua, T., & Huang, A. (2024) · Medicine · doi:10.1097/md.0000000000036908 · Cited by 5
Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
Chahla, B., Stephen, B., Song, J., Balderrama-Brondani, V., Yaylaci, F., Campbell, M. T., Naing, A., & Habra, M. A. (2025) · Journal of Immunotherapy and Precision Oncology · doi:10.36401/jipo-25-6 · Cited by 4
Identification of potential core genes and miRNAs in pediatric ACC via bioinformatics analysis
Fang, C., Ye, Y., Wang, F., Shen, Y., & You, Y. (2022) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2022.01077 · Cited by 4
Laparoscopic surgery for adrenocortical carcinoma: Estimating the risk of margin‐positive resection
Carlisle, K. M., Blackburn, K. W., Japp, E., McArdle, P. F., Turner, D. J., Terhune, J. H., Englum, B. R., Smith, P. W., & Hu, Y. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27544 · Cited by 4
Ma, S., Wu, L., Ye, L., Habra, M. A., Balderrama-Brondani, V., & Wang, W. (2025) · Endocrine · doi:10.1007/s12020-025-04163-5 · Cited by 4
Gene Expression and Regulation in Adrenocortical Tumorigenesis
Fonseca, A. L., Healy, J. M., Kunstman, J. W., Korah, R. M., & Carling, T. (2012) · Biology · doi:10.3390/biology2010026 · Cited by 4
Palter, V. N., Devon, K. M., Hallet, J. I., Kulkarni, G. S., Law, C., & Urbach, D. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-26276-5_1 · Cited by 4
Punjani, N., Clark, R. K., Izawa, J. I., Chin, J. L., Pautler, S. E., & Power, N. E. (2017) · Canadian Urological Association Journal · doi:10.5489/cuaj.4650 · Cited by 4
Chen, H.-C., Tan, E. C., Liao, C.-H., Lin, Z., & Yang, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220730 · Cited by 4
Fisher, S. B., Habra, M. A., Chiang, Y., Wu, S., Graham, P. H., Grubbs, E. G., Lee, J. E., & Perrier, N. D. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05136-2 · Cited by 4
Adrenocortical Cancer: A 20-Year Experience of a Single Referral Center in Prognosis and Outcomes
Zografos, G., Kassi, E. N., Parianos, C., Kyriakopoulos, G., Kostakis, I. D., Ansari, N. N., Aggeli, C., Dimitriadi, A., Angelousi, A. G., Papavassiliou, A. G., et al. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1666-9026 · Cited by 4
Management of adrenocortical carcinoma in Western Australia: a perspective over 14 years
Leong, D. C. W., Nyantoro, M., Shedzad, H., Robins, P. D., Henley, D., Ryan, S., Nguyen, H., & Lisewski, D. (2020) · ANZ Journal of Surgery · doi:10.1111/ans.16111 · Cited by 4
Estrogen-secreting adrenocortical carcinoma
Jeong, Y. C., Cho, S. C., Cho, H. J., Song, J. S., Kong, J. S., Park, J. W., & Ku, Y. H. (2018) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2019.00017 · Cited by 4
Ettaieb, M. H. T. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201218me · Cited by 4
Mayhew, P. D., & Kirpensteijn, J. (2015) · Wiley eBooks · doi:10.1002/9781118845912.ch18 · Cited by 4
Diagnosis and grading of adrenal cortical carcinoma
Trucco, G. V., Duregon, E., Papotti, M. G., & Volante, M. (2025) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-025-04278-0 · Cited by 3
Huang, Y., Liu, L., Gan, Q., Shen, Z., Yao, Y., Liao, C., Lu, S., zou, Y., Huang, Y., Kong, J., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28160 · Cited by 3
Picut, B., Dubuis, J., Demarchi, M. S., & Fournier, I. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-262948 · Cited by 3
Tsai, W.-H., Dai, S.-H., Lee, C., Chien, M.-N., & Zeng, Y.-H. (2023) · Current Oncology · doi:10.3390/curroncol30040313 · Cited by 3
Validated predictive model for treatment and prognosis of adrenocortical carcinoma
Zuber, S. M., Kuchta, K. M., Holoubek, S. A., Khokar, A. M., Moo‐Young, T. A., Prinz, R. A., & Winchester, D. J. (2023) · Surgery · doi:10.1016/j.surg.2023.08.047 · Cited by 3
Self-citationCarcinoma of unknown primary origin with isolated adrenal metastasis: a report of two cases
Kometani, M., Yoneda, T., Maeda, Y., Ohtsubo, K., Yamazaki, Y., Ikeda, H., Mori, S., Aono, D., Karashima, S., Usukura, M., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0141 · Cited by 3
Yaşar, A., Aktaş, B. Y., Uçar, G., Goksu, S. S., Bilgetekin, İ., Çakar, B., Sakin, A., Ateş, Ö., Başoğlu, T., Arslan, Ç., et al. (2024) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2024.102077 · Cited by 3
Adrenocortical Carcinoma: Complete Surgical Resection After 18 Years
Polavarapu, H. V. (2011) · World Journal of Oncology · doi:10.4021/wjon369w · Cited by 3
A current perspective on treatment of adrenocortical carcinoma
Terzolo, M., Francia, S. D., Ardito, A., Perotti, P., Ferrari, L., & Berruti, A. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.931222 · Cited by 3
Mitotane-induced dyspnoea: an unusual side effect
Farooq, A. U., Amjad, W., Kochar, T., & Adhikari, S. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225490 · Cited by 3
Huszty, G., Doros, A., Farkas, K., Kob́ori, L., Reismann, P., Tõke, J., Tóth, M., & Igaz, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.677187 · Cited by 3
A Fly in the Ointment: Reassessing Mitotane‘s Role in the Treatment of Adrenocortical Carcinoma
Bapat, A., Demeure, M. J., & Bussey, K. J. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.90 · Cited by 3
Mayhew, P. D., Araya, F. J. L., & Kirpensteijn, J. (2021) · Wiley eBooks · doi:10.1002/9781119666912.ch17 · Cited by 3
Popova, L. V., Garfinkle, E. A. R., Chopyk, D. M., Navarro, J. B., Rivaldi, A., Shu, Y., Lomonosova, E. E., Phay, J. E., Miller, B. S., Sattuwar, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.30.615695 · Cited by 3
Imaging of Adrenocortical Carcinoma: An Update
Howard, B., Elsayed, A., Klimkowski, S., Lee, J. T., & Elsayes, K. M. (2024) · Seminars in Roentgenology · doi:10.1053/j.ro.2024.11.005 · Cited by 2
Review of Adrenal Androgen Synthesis, Hypersecretion, and Blockade
Olson, P., & Ristau, B. T. (2025) · Urologic Clinics of North America · doi:10.1016/j.ucl.2025.01.004 · Cited by 2
Contemporary Approaches to Adrenocortical Carcinoma
Hughes, A. J., McDow, A. D., Ritter, H. E., & Yang, A. D. (2025) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2025.07.003 · Cited by 2
Elmalı, A., Güler, O. C., Özyiğit, G., Hürmüz, P., & Önal, C. (2025) · International Journal of Urology · doi:10.1111/iju.70319 · Cited by 2
Chirurgische Strategien beim nichtmetastasierten Nebennierenrindenkarzinom
Rayes, N., Quinkler, M. O., & Denecke, T. (2018) · Der Chirurg · doi:10.1007/s00104-017-0582-1 · Cited by 2
Contrast CT radiomic features add value to prediction of prognosis in adrenal cortical carcinoma
Liu, J., Lin, W., Yan, L., Xie, J., Dai, J., Xu, D., & Zhao, J. (2023) · Endocrine · doi:10.1007/s12020-023-03568-4 · Cited by 2
Wang, X., Xu, D., Guo, M.-J., Wang, Y., Zhang, M., & Zhu, D.-X. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i12.2093 · Cited by 2
Öztürk, H. (2024) · Reports of Practical Oncology & Radiotherapy · doi:10.5603/rpor.98727 · Cited by 2
Contemporary Approaches to Adrenocortical Carcinoma
Hughes, A. J., McDow, A. D., Ritter, H. E., & Yang, A. D. (2024) · Advances in Oncology · doi:10.1016/j.yao.2024.11.003 · Cited by 2
Procopio, P. F., Pennestrì, F., Laurino, A., Rossi, E. D., Schinzari, G., Pontecorvi, A., Crea, C. D., & Raffaelli, M. (2025) · Updates in Surgery · doi:10.1007/s13304-025-02215-z · Cited by 2
Clinical Case of Metastatic Adrenocortical Carcinoma With Unusual Evolution: Review the Literature
Cabezón‐Gutiérrez, L., Franco‐Moreno, A., Khosravi‐Shahi, P., Custodio‐Cabello, S., Navarro, M. J. G., & Martin-Diaz, R. M. (2015) · World Journal of Oncology · doi:10.14740/wjon936w · Cited by 2
Feminizing Adrenocortical Tumor with Multiple Recurrences: A Case Report
Rich, J. M., Duddalwar, V. A., Cheng, P. M., Aron, M., & Daneshmand, S. (2023) · Case Reports in Oncology · doi:10.1159/000533835 · Cited by 2
Atypical dissemination of lung cancer to the adrenal gland and to the spleen
Chorąży, M., Majcher, M., Urbanowicz, K. F., Bierzynska-Macyszyn, G., & Kwiatkowski, R. (2012) · Współczesna Onkologia · doi:10.5114/wo.2012.31777 · Cited by 2
Conduite à tenir devant un incidentalome surrénalien
Ménégaux, F., Chéreau, N., Peix, J.-L., Christou, N., Lifante, J. C., Paladino, N. C., Sebag, F. A., Ghander, C., Trésallet, C., & Mathonnet, M. (2014) · Journal de Chirurgie Viscérale · doi:10.1016/j.jchirv.2014.05.005 · Cited by 3
Predictors of malignancy in primary aldosteronism
Agha, A., Hornung, M., Iesalnieks, I., Schreyer, A. G., Jung, E. M., Haneya, A., & Schlitt, H. J. (2013) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-013-1121-2 · Cited by 2
The Challenge of Managing Adrenocortical Carcinoma: Two Case Studies
Kanjanapan, Y., Prasanna, T., Perampalam, S., & Yip, D. (2015) · International Journal of Endocrine Oncology · doi:10.2217/ije.15.12 · Cited by 2
Radiation Therapy for Adrenocortical Carcinoma
Sabolch, A. N., & Ben‐Josef, E. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_25 · Cited by 2
Ji, D., Zhong, R., & Fan, S. (2022) · BioMed Research International · doi:10.1155/2022/8740408 · Cited by 2
RetractedRah, C.-S., Cho, J. W., Kim, W. W., Lee, Y., Chung, K., Koh, J., Lee, S. H., Lee, J., Song, D. E., Hong, S. J., et al. (2022) · Gland Surgery · doi:10.21037/gs-22-274 · Cited by 2
Wu, K., Liu, Z., Li, X., & Lu, Y. (2020) · The American Surgeon · doi:10.1177/0003134820956275 · Cited by 2
Reibetanz, J., Jurowich, C. F., Allolio, B., Faßnacht, M., & Faßnacht, M. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182891efb · Cited by 2
Creemers, S. G., Hofland, L. J., & Feelders, R. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_12 · Cited by 2
Jimenez-Fonseca, P., Álvarez-Escolá, C., Navarro, I. B., Hernando, J., Fernández, L. G., Cruz, M. Á. M., Iglesias, C., García-Donás, J., César, M. J. P., Paja, M., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf171 · Cited by 1
Lattice radiotherapy for palliation in a case of metastatic adrenocortical carcinoma
Jayashree, N. P., Shambhavi, C., Malapure, S. S., Pai, A., Salins, N., & Lewis, S. C. (2026) · International Cancer Conference Journal · doi:10.1007/s13691-026-00845-7 · Cited by 1
Flauto, F., Neola, G., Vitale, F., & Damiano, V. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105346 · Cited by 1
Carcinoma adrenocortical: presentación y desenlaces en una institución oncológica
Maya, L. F. F., Clavijo, A. ́. G., Madero, A. I., Cuellar, A. A. C., & Carreño-Dueñas, J. A. (2021) · Revista Colombiana de Cancerología · doi:10.35509/01239015.108 · Cited by 1
Fassari, A., Petramala, L., Letizia, C., & Cavallaro, G. (2023) · Indian Journal of Surgery · doi:10.1007/s12262-023-03958-y · Cited by 1
Chen, T., Zeng, D., Zhou, G., Qin, L., & Qian, X. (2025) · Medicine · doi:10.1097/md.0000000000042831 · Cited by 1
Bilateral and recurrent adrenocortical carcinoma in MEN1: a case report and review of the literature
Howarth, S., MacFarlane, J., Palma, A., Stokes, V. J., Challis, B., Ang, J. E., Harper, I. G., Cheow, H., Tadross, J. A., Shaw, A., et al. (2025) · Endocrine Oncology · doi:10.1530/eo-25-0067 · Cited by 1
Innovative molecular targets for combatting metastasis in adrenocortical carcinoma
Kong, J., Chen, X., Fan, X., Fang, S., Zhang, Q., Zhang, L., Liao, C., He, Q., Xie, W., Xing, Y., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1516467 · Cited by 1
van Baal, L., Lahner, H., Pavlović, J., Moeller, L. C., Unger, N., Führer-Sakel, D., & Mathew, A. (2026) · Endocrine Connections · doi:10.1530/ec-25-0709 · Cited by 1
Economopoulou, P., Mountzios, G., Kotsantis, I., Bakogeorgos, M., Ramfidis, V., Kapiris, I., Patsouris, E., & Kentepozidis, N. K. (2013) · Case Reports in Medicine · doi:10.1155/2013/461409 · Cited by 1
Adrenocortical carcinoma presenting with a peritoneal effusion
Arvanitis, L. D., Pitelka, L. A., & Gattuso, P. (2009) · Diagnostic Cytopathology · doi:10.1002/dc.21261 · Cited by 1
A Case of Adrenocortical Carcinoma Secreting Cortisol, Androgen and Aldosterone
Choi, J. H., So, Y. R., Hwang, Y. C., Jeong, I., Ahn, K. J., Chung, H. Y., & Yang, S.-A. (2011) · Endocrinology and Metabolism · doi:10.3803/enm.2011.26.3.239 · Cited by 1
McAlpine, K., Mookerji, N., Lavallée, L. T., & WATTERSON, J. D. (2017) · Canadian Urological Association Journal · doi:10.5489/cuaj.4843 · Cited by 1
A case of metastatic liver cancer with hormone secretion: a case report
Quan, C., Zhang, Y., & Wang, Y. (2021) · Gland Surgery · doi:10.21037/gs-21-296 · Cited by 1
Allolio, B., Nies, C., Moll, R., Klose, K., Kann, P. H., Pfestroff, A., Waldmann, J., Bartsch, D. K., Lehnert, H., Dralle, H., et al. (2012) · Springer eBooks · doi:10.1007/978-3-642-14285-7_4 · Cited by 1
Adrenal cytomegaly with elevated serum androgen levels in a patient with Beckwith-Wiedemann syndrome
Aoki, M., Uehara, S., Nishimaki, H., Aoki, R., Kayama, K., Nagano, N., Urakami, T., & Morioka, I. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0261 · Cited by 1
Brain and Adrenal Metastasis From Unknown Primary Tumor: A Case Report
Katsumata, R., Monobe, Y., Akagi, A., Yamatsuji, T., & Naomoto, Y. (2022) · Cureus · doi:10.7759/cureus.26438 · Cited by 1
Prognostic markers of recurrence in adrenocortical carcinoma patients after surgery
Kalugina, V. V., Ворохобина, Н. В., Великанова, Л. И., Ривгатовна, Ш. З., Валерьевна, М. Е., Геннадьевна, С. Е., Bokhyan, V. Y., Альбертович, Б. Т., & Кушлинский, Н. Е. (2023) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov233493 · Cited by 1
Challenges and controversies in adrenal surgery: A practical approach
Beninato, T. M., Duh, Q., Long, K. L., Kiernan, C. M., Miller, B. S., Patel, S. G., Randle, R. W., Wachtel, H., Zanocco, K. A., Zern, N. K., et al. (2023) · Current Problems in Surgery · doi:10.1016/j.cpsurg.2023.101374 · Cited by 1
Kwon, D., Rah, C.-S., Kim, B.-C., Pak, S. J., Cho, J. W., Kim, W. W., Lee, Y., Lee, J., Song, D. E., Chung, K., et al. (2024) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2024.107.4.187 · Cited by 1
Identifying genomic signatures of recurrence in adrenocortical carcinoma after R0 resection
Greenspun, B. C., Chirko, D., Toor, R., Wierzbicki, K., Marshall, T. E., Tumati, A., Zarnegar, R., Fahey, T. J., & Finnerty, B. M. (2024) · Surgery · doi:10.1016/j.surg.2024.09.036 · Cited by 1
Singer, A. E., Kathuria‐Prakash, N., Shabsovich, D., Garcia, L., Damron, L. F., Pantuck, A. J., & Drakaki, A. (2025) · Clinical Medicine Insights Oncology · doi:10.1177/11795549251364042 · Cited by 1
CLINICOPATHOLOGIC CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH ADRENOCORTICAL CARCINOMA
Miura, N., Ide, T., Uda, T., Noda, T., Asai, S., Nishimura, K., Shirato, A., Yanagihara, Y., Miyauchi, Y., Kikugawa, T., et al. (2014) · The Japanese Journal of Urology · doi:10.5980/jpnjurol.105.79 · Cited by 1
RESULTS OF DIAGNOSTICS AND TREATMENT OF ADRENOCORTICAL CANCER
Николаевич, Р. П., Maistrenko, N. A., Орлова, Р. В., & Babich, A. I. (2015) · Grekov s Bulletin of Surgery · doi:10.24884/0042-4625-2015-174-3-29-39 · Cited by 1
Cabezón‐Gutiérrez, L., Khosravi‐Shahi, P., Custodio‐Cabello, S., Luján-Rodríguez, D. R., Garijo-Álvarez, J. Á., Causso-Lariena, C. M., & Franco‐Moreno, A. (2017) · Medwave · doi:10.5867/medwave.2017.06.7007 · Cited by 1
Surgery for Adrenocortical Cancer: Evidence-Based Recommendations
Mihai, R. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_29 · Cited by 1
Disseminated Invasive Aspergillosis in a Patient with Adrenocortical Carcinoma
Cardenas, S. M. C., Colovic, K., Nicol, T. L., Maleki, Z., & Krug, E. I. (2019) · AACE Clinical Case Reports · doi:10.4158/accr-2019-0016 · Cited by 1
Chirurgie der Nebennierenerkrankungen
Schimmack, S. J., Knoell, P., Kihm, L., & Strobel, O. (2020) · Der Chirurg · doi:10.1007/s00104-020-01230-7 · Cited by 1
Hypoglycemia in a Patient with Hypercortisolism and Adrenocortical Carcinoma: A Paradoxical Entity
Khadka, S., Mandal, S., Kasireddy, V., Ghimire, S., Maganti, T., & Mols-Kowalczewski, B. L. (2021) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2020.0229 · Cited by 1
A transcription factor signature predicts the survival of patients with adrenocortical carcinoma
Zhao, J., Liu, B., & Li, X. (2021) · PeerJ · doi:10.7717/peerj.12433 · Cited by 1
Chihara, I., Nagumo, Y., Kandori, S., Kojo, K., Sano, K., Hamada, K., Tanuma, K., Tsuchiya, H., Shiga, M., Sakka, S., et al. (2022) · International Journal of Urology · doi:10.1111/iju.14996 · Cited by 1
Kitsugi, K., Kawata, K., Kakizawa, K., & Noritake, H. (2023) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/23247096231218135 · Cited by 1
Embracing National Cancer Registries for Improved Care of Rare Tumors
Schneider, D. F. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3934-9 · Cited by 1
CpG Island Methylator Phenotype in Adrenocortical Carcinoma: Fact or Fiction?
Liu‐Chittenden, Y., & Kebebew, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4063 · Cited by 1
Self-citation
Metadata
- Authors
- Bilimoria, K. Y., Shen, W. T., Elaraj, D., Bentrem, D. J., Winchester, D. J., Kebebew, E., & Sturgeon, C.
- Affiliations
- Northwestern University (US)
- University of California, San Francisco (US)
- Corresponding author
- Bilimoria, Karl Y.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-10-30
- Volume
- 113
- Issue
- 11
- Pages
- 3130-3136
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1994325777
- Cited by
- 493
- References
- 22
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 29 · 2023: 28 · 2022: 28 · 2021: 45 · 2020: 39 · 2019: 29 · 2018: 39 · 2017: 31 · 2016: 26 · 2015: 35 · 2014: 24 · 2013: 19 · 2012: 29
- FWCI
- 17.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenocortical carcinoma, adrenalectomy, surgical resection, long-term survival, prognostic factors, tumor differentiation, positive resection margins, lymph node metastasis, distant metastasis, adjuvant chemotherapy, adjuvant radiotherapy, treatment utilization, age at diagnosis
- MeSH terms
- Adrenal Cortex Neoplasms, Adult, Aged, Female, Humans, Male, Middle Aged, Prognosis, Registries, United States, Survival Analysis, Treatment Outcome, Adrenocortical Carcinoma, Disease-Free Survival
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
